Multiple Sclerosis Journal

Aims & Scope

Multiple Sclerosis Journal is a peer-reviewed international journal that focuses on all aspects of multiple sclerosis, neuromyelitis optica and other related autoimmune diseases of the central nervous system.

The journal for your research in the following areas: • Biologic basis: pathology, myelin biology, pathophysiology of the blood/brain barrier, axo-glial pathobiology, remyelination, virology and microbiome, immunology, proteomics, experimental models • Epidemology and genetics: genetics epigenetics, epidemiology • Clinical and Neuroimaging: clinical neurology, biomarkers, neuroimaging, Clinical Trials and clinical outcome measures, • Therapeutics and rehabilitation: therapeutics, rehabilitation, psychology, neuroplasticity, neuroprotection, and systematic management Outstanding information presented in a topical based format.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	5
2024	4.80

SJR (SCImago Journal Rank)

Year	Value
2024	1.938

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	160

Journal Rank

Year	Value
2024	1534

Journal Citation Indicator

Year	Value
2024	3313

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Neuroscience, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition

  Citation: 1919

  Authors: Clare, Rachel, Lindsay, Wendy, Emmanuelle, Ruth Ann, Neil, Nicholas, Bernard, Ingrid, Mitchell, Anne, Ceri, Nick, Peer

• International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions

  Citation: 948

  Authors: Lauren B, Marc, Maria Pia, Brenda, Tanuja, Russell C, Angelo, Rogier, Andrew, Daniela, Kevin, Silvia, Evangeline

• The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment

  Citation: 778

  Authors: J S, R A, G R, S C

• Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis

  Citation: 716

  Authors: Ralph HB, John, Glenn, Nicholas, Lynn D, Richard

• Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS)

  Citation: 714

  Authors: DW, MP, J, B, F, S, P, H-P, L, IK, AT, RHB

• New insights into the burden and costs of multiple sclerosis in Europe

  Citation: 599

  Authors: Gisela, Alan, Jenny, Mia, Jennifer

• Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis

  Citation: 581

  Authors: D, P, B, N, V, S, H

• ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis

  Citation: 553

  Authors: Xavier, Ralf, Alan J, Susana, Maria Pia, Dhia, Michel, Giancarlo, Tobias, Franz, Hans Peter, Eva, Bernhard, Ludwig, Roland, Catherine, Elena, David H, Tomas, Steve, Krysztof, Aksel, Per Soelberg, Maria Pia, Christoph, Heinz, Frauke

• Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls

  Citation: 547

  Authors: Myla D, Ruth Ann, Jeffrey A

• Differential diagnosis of suspected multiple sclerosis: a consensus approach

  Citation: 525

  Authors: DH, BG, M, BL, JA, MS, SL, M, RT, L, J, FD, HF, X, H, JR, SC, CH

---